EcoDrugPlus

Ensembl ID : ENSBGRG00000026855
Gene Symbol: -
Cross references: -
237 Possible Orthologues:

Ensembl ID : ENSBGRG00000002368
Gene Symbol: -
Cross references: -
393 Possible Orthologues:

Ensembl ID : ENSBGRG00000001908
Gene Symbol: -
Cross references: -
348 Possible Orthologues:

Ensembl ID : ENSBGRG00000001517
Gene Symbol: -
Cross references: -
403 Possible Orthologues:

Ensembl ID : ENSBGRG00000003539
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Ensembl ID : ENSBGRG00000021369
Gene Symbol: -
Cross references: -
80 Possible Orthologues:

Ensembl ID : ENSBGRG00000001267
Gene Symbol: -
Cross references: -
272 Possible Orthologues:

Ensembl ID : ENSBGRG00000005885
Gene Symbol: -
Cross references: -
84 Possible Orthologues:

Ensembl ID : ENSBGRG00000002274
Gene Symbol: -
Cross references: -
74 Possible Orthologues:

Ensembl ID : ENSBGRG00000000130
Gene Symbol: -
Cross references: -
272 Possible Orthologues:

Ensembl ID : ENSBGRG00000003349
Gene Symbol: -
Cross references: -
159 Possible Orthologues:

Ensembl ID : ENSBGRG00000001832
Gene Symbol: -
Cross references: -
264 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).